Non-invasive ventilation in amyotrophic lateral sclerosis
Non-invasive ventilation (NIV) has become an important cornerstone of symptomatic treatment in amyotrophic lateral sclerosis (ALS), improving survival and quality of life. In this review, we summarize the most important recent developments and insights, including evidence of efficacy, indication cri...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-06-01
|
Series: | Therapeutic Advances in Neurological Disorders |
Online Access: | https://doi.org/10.1177/1756286419857040 |
id |
doaj-1782b652021c469fab4b4bc418cb89a7 |
---|---|
record_format |
Article |
spelling |
doaj-1782b652021c469fab4b4bc418cb89a72020-11-25T03:19:21ZengSAGE PublishingTherapeutic Advances in Neurological Disorders1756-28642019-06-011210.1177/1756286419857040Non-invasive ventilation in amyotrophic lateral sclerosisJohannes DorstAlbert C. LudolphNon-invasive ventilation (NIV) has become an important cornerstone of symptomatic treatment in amyotrophic lateral sclerosis (ALS), improving survival and quality of life. In this review, we summarize the most important recent developments and insights, including evidence of efficacy, indication criteria and time of initiation, ventilation parameters and adaptation strategies, treatment of complicating factors, transition from NIV to invasive ventilation, termination of NIV and end-of-life management. Recent publications have questioned former conventions and guideline recommendations, especially with regard to timing and prognostic factors; therefore, a fresh look and re-evaluation of current evidence is needed.https://doi.org/10.1177/1756286419857040 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Johannes Dorst Albert C. Ludolph |
spellingShingle |
Johannes Dorst Albert C. Ludolph Non-invasive ventilation in amyotrophic lateral sclerosis Therapeutic Advances in Neurological Disorders |
author_facet |
Johannes Dorst Albert C. Ludolph |
author_sort |
Johannes Dorst |
title |
Non-invasive ventilation in amyotrophic lateral sclerosis |
title_short |
Non-invasive ventilation in amyotrophic lateral sclerosis |
title_full |
Non-invasive ventilation in amyotrophic lateral sclerosis |
title_fullStr |
Non-invasive ventilation in amyotrophic lateral sclerosis |
title_full_unstemmed |
Non-invasive ventilation in amyotrophic lateral sclerosis |
title_sort |
non-invasive ventilation in amyotrophic lateral sclerosis |
publisher |
SAGE Publishing |
series |
Therapeutic Advances in Neurological Disorders |
issn |
1756-2864 |
publishDate |
2019-06-01 |
description |
Non-invasive ventilation (NIV) has become an important cornerstone of symptomatic treatment in amyotrophic lateral sclerosis (ALS), improving survival and quality of life. In this review, we summarize the most important recent developments and insights, including evidence of efficacy, indication criteria and time of initiation, ventilation parameters and adaptation strategies, treatment of complicating factors, transition from NIV to invasive ventilation, termination of NIV and end-of-life management. Recent publications have questioned former conventions and guideline recommendations, especially with regard to timing and prognostic factors; therefore, a fresh look and re-evaluation of current evidence is needed. |
url |
https://doi.org/10.1177/1756286419857040 |
work_keys_str_mv |
AT johannesdorst noninvasiveventilationinamyotrophiclateralsclerosis AT albertcludolph noninvasiveventilationinamyotrophiclateralsclerosis |
_version_ |
1724622952979234816 |